Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

#CACA2024

Home » #CACA2024
Dr. Yuan Yu’s Insights: Advances in Esophageal Cancer Nursing and Future Directions for Enhanced Recovery | CACA Integrated Esophageal Cancer Academic

Dr. Yuan Yu’s Insights: Advances in Esophageal Cancer Nursing and Future Directions for Enhanced Recovery | CACA Integrated Esophageal Cancer Academic

Posted by By Peter W. PENG 2024.10.26
Editor's Note: At the 2024 CACA Integrated Esophageal Cancer Academic Conference, Dr. Yuan Yu, the inaugural chairman of the CACA Committee on Integrated Nursing for Esophageal Cancer and a leading…
Read More
Minimally Invasive Surgery and Immunotherapy Dr. Yongde Liao Discusses New Pathways in Esophageal Cancer Treatment | CACA Integrated Esophageal Cancer

Minimally Invasive Surgery and Immunotherapy Dr. Yongde Liao Discusses New Pathways in Esophageal Cancer Treatment | CACA Integrated Esophageal Cancer

Posted by By Lisa Cui 2024.10.26
Editor's Note: From September 26 to 28, 2024, the 2024 CACA Integrated Esophageal Cancer Academic Conference, hosted by the Chinese Anti-Cancer Association and the CACA Esophageal Cancer Committee, was successfully…
Read More
Dr. Feng Wang: Current Status and Challenges of Hepatocellular Carcinoma (HCC) Conversion Therapy in the Era of Integrated Medicine

Dr. Feng Wang: Current Status and Challenges of Hepatocellular Carcinoma (HCC) Conversion Therapy in the Era of Integrated Medicine

Posted by By Lisa Cui 2024.10.08
Liver cancer is one of the most common malignant tumors in China, ranking second in cancer-related deaths. This highlights the significant burden of liver cancer prevention and treatment in the…
Read More
Recent Posts
  • BOC 2026 | Prof. Pei Dong: Kidney Cancer Enters the Era of Long-Term Survival, with New Advances in Adjuvant Therapy and Comprehensive Disease Management
  • BOC 2026 | Prof. Wasilijiang-Wahafu: Neoadjuvant Therapy for MIBC Enters a New Era with Precision Stratification and Comprehensive Perioperative Management
  • CUDA 2026 | Prof. Nianzeng Xing: Advancing Urology Through Collaboration and Innovation
  • CUDA 2026 | Rethinking Tiered Healthcare and Multidisciplinary Care in Urology—An Interview with Prof. Zhisong He
  • CUDA 2026 | Prof. Xingyuan Xiao: Rethinking Comprehensive Urologic Cancer Management Through the Integration of Traditional Chinese and Western Medicine and MDT
Recent Comments
    Archives
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top